Circadian variation in nivolumab efficacy in patients with advanced non-small cell lung cancer.

被引：0
|
作者：
Karabou, Abdoulaye
Bisseux, Laurence
Pavese, Ida
Collon, Thierry
机构：
[1] Montfermeil Hosp, GHT Grand Paris Est, Med Oncol Unit, Montfermeil, France
[2] GHI LE Raincy Montfermeil, Montfermeil, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21585
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Circadian function of patients with advanced non-small cell lung cancer.
    Levin, RD
    Grutsch, JF
    Hrushesky, WJM
    Quiton, J
    Quinn, K
    Daehler, M
    Lis, CG
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 693S - 693S
  • [2] Circadian function in patients with advanced non-small cell lung cancer.
    Levin, Robert D.
    Lis, Christopher G.
    Peterson, Caryn
    Grutsch, James F.
    Hrushesky, William Jm
    Quiton, Jovelyn
    Quinn, Kathleen
    Daehler, Maryann
    Gupta, Digant
    CANCER RESEARCH, 2006, 66 (08)
  • [3] Circadian function in patients with advanced non-small cell lung cancer.
    Daehier, Mary
    Levin, Robert
    Grutsch, James
    Jardinico, Joy
    Hrushesky, William
    ONCOLOGY NURSING FORUM, 2007, 34 (01) : 213 - 214
  • [4] Efficacy and Tolerability of Nivolumab in Elderly Patients with Advanced Non-Small Cell Lung Cancer
    Yamane, K.
    Takeda, K.
    Yanai, M.
    Tanaka, N.
    Izumi, H.
    Sakamoto, T.
    Yamaguchi, K.
    Yamasaki, A.
    Igishi, T.
    Eiji, S.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1918 - S1918
  • [5] The safety and efficacy of nivolumab in advanced (metastatic) non-small cell lung cancer
    Tanvetyanon, Tawee
    Creelan, Benjamin C.
    Antonia, Scott J.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (09) : 903 - 910
  • [6] Advanced non-small cell lung cancer.
    Edelman M.J.
    Khanwani S.L.
    Current Treatment Options in Oncology, 2001, 2 (1) : 51 - 62
  • [7] POPULATION PHARMACOKINETICS OF NIVOLUMAB IN JAPANESE PATIENTS WITH NON-SMALL CELL LUNG CANCER.
    Tohi, M.
    Mizuno, T.
    Irie, K.
    Okuyoshi, H.
    Hirabatake, M.
    Ikesue, H.
    Muroi, N.
    Eto, M.
    Tomii, K.
    Hashida, T.
    Fukushima, S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 : S97 - S97
  • [8] Long term effect of nivolumab in patients with non-small cell lung cancer.
    Sprauten, Mette
    Flote, Vidar
    Brustugun, Odd Terje
    Helland, Aslaug
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [9] Efficacy of subsequent cytotoxic chemotherapy after nivolumab for patients with advanced non-small cell lung cancer
    Tamura, N.
    Horinouchi, H.
    Sekine, K.
    Matsumoto, Y.
    Murakami, S.
    Goto, Y.
    Kanda, S.
    Fujiwara, Y.
    Yamamoto, N.
    Ohe, Y.
    ANNALS OF ONCOLOGY, 2017, 28
  • [10] Efficacy and safety of nivolumab in Japanese patients with advanced or recurrent squamous non-small cell lung cancer
    Hida, Toyoaki
    Nishio, Makoto
    Nogami, Naoyuki
    Ohe, Yuichiro
    Nokihara, Hiroshi
    Sakai, Hiroshi
    Satouchi, Miyako
    Nakagawa, Kazuhiko
    Takenoyama, Mitsuhiro
    Isobe, Hiroshi
    Fujita, Shiro
    Tanaka, Hiroshi
    Minato, Koichi
    Takahashi, Toshiaki
    Maemondo, Makoto
    Takeda, Koji
    Saka, Hideo
    Goto, Koichi
    Atagi, Shinji
    Hirashima, Tomonori
    Sumiyoshi, Naoki
    Tamura, Tomohide
    CANCER SCIENCE, 2017, 108 (05) : 1000 - 1006
12345